Peter Völker

Antiproliferative Signaling of Luteinizing Hormone-Releasing Hormone in Human Endometrial and Ovarian Cancer Cells through G Proteinα I-Mediated Activation of Phosphotyrosine Phosphatase*

Carsten Gründker, Peter Völker, Günter Emons · Endocrinology · 2001 · 141 citations · Full text

Gynecology, Ovarian Cancer, Signaling Pathway +20

Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: Frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues

Peter Völker, Carsten Gründker, Oswald Schmidt et al. · American Journal of Obstetrics and Gynecology · 2002 · 125 citations

Hormone-releasing Hormone Analogues, Medicine, Hormonal Receptor +9

Antitumor effects of the cytotoxic luteinizing hormone–releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice

Carsten Gründker, Peter Völker, Frank Griesinger et al. · American Journal of Obstetrics and Gynecology · 2002 · 89 citations

Hormone Analog An-152, Oncology, Ovarian Cancers +12

Luteinizing Hormone–Releasing Hormone Agonist Triptorelin and Antagonist Cetrorelix Inhibit EGF-Induced c-fos Expression in Human Gynecological Cancers

Carsten Gründker, Peter Völker, Klaus-Dieter Schulz et al. · Gynecologic Oncology · 2000 · 78 citations

Endocrine Oncology, Oncology, Medicine +6

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

Claire F. Verschraegen, Silke Westphalen, Wei Hu et al. · Gynecologic Oncology · 2003 · 43 citations

Medicine, Pharmacology, Gynecology +8